Cargando…
Alternative strategies in cardiac preclinical research and new clinical trial formats
An efficient and safe drug development process is crucial for the establishment of new drugs on the market aiming to increase quality of life and life-span of our patients. Despite technological advances in the past decade, successful launches of drug candidates per year remain low. We here give an...
Autores principales: | Kreutzer, Fabian Philipp, Meinecke, Anna, Schmidt, Kevin, Fiedler, Jan, Thum, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989574/ https://www.ncbi.nlm.nih.gov/pubmed/33693475 http://dx.doi.org/10.1093/cvr/cvab075 |
Ejemplares similares
-
Development and characterization of anti-fibrotic natural compound similars with improved effectivity
por: Kreutzer, Fabian Philipp, et al.
Publicado: (2022) -
Integrative Bioinformatic Analyses of Global Transcriptome Data Decipher Novel Molecular Insights into Cardiac Anti-Fibrotic Therapies
por: Fuchs, Maximilian, et al.
Publicado: (2020) -
An alternative pathway for preclinical research in fluid management
por: Sibbald, William J
Publicado: (2000) -
Comprehensive Bioinformatics Identifies Key microRNA Players in ATG7-Deficient Lung Fibroblasts
por: Stojanović, Stevan D., et al.
Publicado: (2020) -
Do alternatives to animal experimentation replace preclinical research?
por: Mahalmani, Vidya, et al.
Publicado: (2023)